Cargando…
Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma
BACKGROUND: Osteosarcoma in dogs and humans share many similarities and the dog has been described as an excellent model to study this disease. The median survival in dogs has not improved in the last 25 years. Taurolidine has been shown to be cytotoxic to canine and human osteosarcoma in vitro. The...
Autores principales: | Marley, Kevin, Helfand, Stuart C, Simpson, Jennifer, Mata, John E, Tracewell, William G, Brownlee, Lisa, Bracha, Shay, Séguin, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852505/ https://www.ncbi.nlm.nih.gov/pubmed/24422857 http://dx.doi.org/10.1186/1756-9966-32-74 |
Ejemplares similares
-
The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro
por: Marley, Kevin, et al.
Publicado: (2013) -
Dasatinib Modulates Invasive and Migratory Properties of Canine Osteosarcoma and has Therapeutic Potential in Affected Dogs
por: Marley, Kevin, et al.
Publicado: (2015) -
Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro
por: Milovancev, Milan, et al.
Publicado: (2016) -
The expression and role of serotonin receptor 5HTR2A in canine osteoblasts and an osteosarcoma cell line
por: Bracha, Shay, et al.
Publicado: (2013) -
Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts
por: Milovancev, Milan, et al.
Publicado: (2013)